MaxCyte, Inc. Increase (Decrease) in Other Noncurrent Assets
MaxCyte, Inc. (MXCT) reported Increase (Decrease) in Other Noncurrent Assets of -$1.45 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInOtherNoncurrentAssets · last filed 2026-08-13
- MaxCyte, Inc. increase (decrease) in other noncurrent assets for the quarter ending 2026-06-30 was -$1.58M, a 277.88% decline year-over-year.
- MaxCyte, Inc. increase (decrease) in other noncurrent assets for the quarter ending 2026-03-31 was $127.00K, a 50.00% decline year-over-year.
- MaxCyte, Inc. increase (decrease) in other noncurrent assets for the quarter ending 2025-12-31 was -$200.00K, a 141.58% decline year-over-year.
- MaxCyte, Inc. increase (decrease) in other noncurrent assets for the quarter ending 2025-09-30 was -$216.00K, a 152.55% decline year-over-year.
- MaxCyte, Inc. increase (decrease) in other noncurrent assets for fiscal 2025 was $724.00K, a 40.31% decline from fiscal 2024.
- MaxCyte, Inc. increase (decrease) in other noncurrent assets for fiscal 2024 was $1.21M.
- MaxCyte, Inc. increase (decrease) in other noncurrent assets for fiscal 2023 was -$421.00K, a 185.57% decline from fiscal 2022.
- MaxCyte, Inc. increase (decrease) in other noncurrent assets for fiscal 2022 was $492.00K, a 73.97% increase from fiscal 2021.
| Period end | Increase (Decrease) in Other Noncurrent Assets 3 month | Increase (Decrease) in Other Noncurrent Assets 3 month as first filed | Increase (Decrease) in Other Noncurrent Assets 6 month | Increase (Decrease) in Other Noncurrent Assets 6 month as first filed | Increase (Decrease) in Other Noncurrent Assets 9 month | Increase (Decrease) in Other Noncurrent Assets 9 month as first filed | Increase (Decrease) in Other Noncurrent Assets 12 month | Increase (Decrease) in Other Noncurrent Assets 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | -$1.58M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-13 | -$1.45M 10-Q · filed 2026-08-13 | -$1.65M derived: sum of 3 quarters · filed 2026-08-13 | -$1.86M derived: sum of 4 quarters · filed 2026-08-13 | ||||
| 2026-03-31 | $127.00K 10-Q · filed 2026-05-13 | -$73.00K derived: sum of 2 quarters · filed 2026-05-13 | -$289.00K derived: sum of 3 quarters · filed 2026-05-13 | $597.00K derived: sum of 4 quarters · filed 2026-08-13 | ||||
| 2025-12-31 | -$200.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-25 | -$416.00K derived: sum of 2 quarters · filed 2026-03-25 | $470.00K derived: sum of 3 quarters · filed 2026-08-13 | $724.00K 10-K · filed 2026-03-25 | ||||
| 2025-09-30 | -$216.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-13 | $670.00K derived: sum of 2 quarters · filed 2026-08-13 | $924.00K 10-Q · filed 2025-11-13 | $1.41M derived: sum of 4 quarters · filed 2026-08-13 | ||||
| 2025-06-30 | $886.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-13 | $1.14M 10-Q · filed 2026-08-13 | $1.62M derived: sum of 3 quarters · filed 2026-08-13 | $2.03M derived: sum of 4 quarters · filed 2026-08-13 | ||||
| 2025-03-31 | $254.00K 10-Q · filed 2026-05-13 | $735.00K derived: sum of 2 quarters · filed 2026-05-13 | $1.15M derived: sum of 3 quarters · filed 2026-05-13 | $1.50M derived: sum of 4 quarters · filed 2026-05-13 | ||||
| 2024-12-31 | $481.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-25 | $892.00K derived: sum of 2 quarters · filed 2026-03-25 | $1.25M derived: sum of 3 quarters · filed 2026-03-25 | $1.21M 10-K · filed 2026-03-25 | ||||
| 2024-09-30 | $411.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-13 | $765.00K derived: sum of 2 quarters · filed 2025-11-13 | $732.00K 10-Q · filed 2025-11-13 | $501.00K derived: sum of 4 quarters · filed 2025-11-13 | ||||
| 2024-06-30 | $354.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-06 | $321.00K 10-Q · filed 2025-08-06 | $90.00K derived: sum of 3 quarters · filed 2025-08-06 | $112.00K derived: sum of 4 quarters · filed 2025-08-06 | ||||
| 2024-03-31 | -$33.00K 10-Q · filed 2025-05-08 | -$264.00K derived: sum of 2 quarters · filed 2025-05-08 | -$242.00K derived: sum of 3 quarters · filed 2025-05-08 | -$44.00K derived: sum of 4 quarters · filed 2025-05-08 | ||||
| 2023-12-31 | -$231.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-11 | -$209.00K derived: sum of 2 quarters · filed 2025-03-11 | -$11.00K derived: sum of 3 quarters · filed 2025-03-11 | -$421.00K 10-K · filed 2025-03-11 | ||||
| 2023-09-30 | $22.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-06 | $220.00K derived: sum of 2 quarters · filed 2024-11-06 | -$190.00K 10-Q · filed 2024-11-06 | -$189.60K 10-Q · filed 2023-11-08 | -$571.10K derived: sum of 4 quarters · filed 2024-11-06 | |||
| 2023-06-30 | $198.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-06 | -$212.00K 10-Q · filed 2024-08-06 | -$211.70K 10-Q · filed 2023-08-09 | -$593.10K derived: sum of 3 quarters · filed 2024-08-06 | -$323.80K derived: sum of 4 quarters · filed 2024-08-06 | |||
| 2023-03-31 | -$410.00K 10-Q · filed 2024-05-07 | -$409.70K 10-Q · filed 2023-05-10 | -$791.10K derived: sum of 2 quarters · filed 2024-05-07 | -$521.80K derived: sum of 3 quarters · filed 2024-05-07 | -$656.20K derived: sum of 4 quarters · filed 2024-05-07 | |||
| 2022-12-31 | -$381.10K derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-12 | -$111.80K derived: sum of 2 quarters · filed 2024-03-12 | -$246.20K derived: sum of 3 quarters · filed 2024-03-12 | $492.00K 10-K · filed 2024-03-12 | $492.30K 10-K · filed 2023-03-15 | |||
| 2022-09-30 | $269.30K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-08 | $134.90K derived: sum of 2 quarters · filed 2023-11-08 | $873.10K 10-Q · filed 2023-11-08 | $871.70K derived: sum of 4 quarters · filed 2023-11-08 | ||||
| 2022-06-30 | -$134.40K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-09 | $603.80K 10-Q · filed 2023-08-09 | $602.40K derived: sum of 3 quarters · filed 2023-08-09 | -$783.60K derived: sum of 4 quarters · filed 2023-08-09 | ||||
| 2022-03-31 | $738.20K 10-Q · filed 2023-05-10 | $736.80K derived: sum of 2 quarters · filed 2023-05-10 | -$649.20K derived: sum of 3 quarters · filed 2023-05-10 | $971.90K derived: sum of 4 quarters · filed 2023-05-10 | ||||
| 2021-12-31 | -$1.40K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-15 | -$1.39M derived: sum of 2 quarters · filed 2023-03-15 | $233.70K derived: sum of 3 quarters · filed 2023-03-15 | $282.80K 10-K · filed 2023-03-15 | ||||
| 2021-09-30 | -$1.39M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-09 | $235.10K derived: sum of 2 quarters · filed 2022-11-09 | $284.20K 10-Q · filed 2022-11-09 | $284.20K derived: sum of 4 quarters · filed 2022-11-09 | ||||
| 2021-06-30 | $1.62M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-10 | $1.67M 10-Q · filed 2022-08-10 | $1.67M derived: sum of 3 quarters · filed 2022-08-10 | $1.60M derived: sum of 4 quarters · filed 2022-08-10 | ||||
| 2021-03-31 | $49.10K 10-Q · filed 2022-05-09 | $49.10K derived: sum of 2 quarters · filed 2022-05-09 | -$17.00K derived: sum of 3 quarters · filed 2022-05-09 | |||||
| 2020-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-22 | -$66.10K derived: sum of 2 quarters · filed 2022-03-22 | $33.90K 10-K · filed 2022-03-22 | |||||
| 2020-09-30 | -$66.10K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-10 | $33.90K 10-Q · filed 2021-11-10 | ||||||
| 2020-06-30 | $100.00K 10-Q · filed 2021-09-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| bioAffinity Technologies, Inc. (BIAF) | United States | $0.063B | |
| OneMedNet Corp (ONMD) | $0.042B | ||
| iSpecimen Inc. (ISPC) | United States | $0.003B | |
| FOXO TECHNOLOGIES INC. (FOXO) | United States | $0.000B | -277.71 |
| NRC HEALTH (NRC) | United States | $0.450B | 42.50 |
| OmniAb, Inc. (OABI) | United States | $0.698B | -8.05 |
| Absci Corp (ABSI) | United States | $1.775B | -14.92 |
| CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL) | United States | $14.060B | -43.97 |
| Medpace Holdings, Inc. (MEDP) | United States | $17.316B | 30.09 |
| INCYTE CORP (INCY) | United States | $24.855B | 13.14 |